Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.
Where to find us
Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com
The Highlights
Shilpa Biocare Invests in Gate2Brain to Advance G2B-002, an Innovative Brain Cancer Therapeutic Candidate
Funding & Breakthroughs, Highlights, News, Press releasesSpain & India, working in the clinical development for a novel therapy against pediatric brain tumors
HighlightsGate2Brain part of the CDTI’s NEOTEC program
Highlights, NewsGate2Brain receives €2,5M funding from EIC to develop its technology
Highlights, Press releasesThree University of Barcelona spin-offs receive funding from Women TechEU
Highlights, NewsBStartup of Banco de Sabadell invests in Gate2Brain biotech
Funding & Breakthroughs, Highlights, Press releasesThe Mind the Gap program of Botín Foundation invests 1.5 million euros in three new biotech startups
Highlights, Media & Press, Press releasesShilpa Biocare Invests in Gate2Brain to Advance G2B-002, an Innovative Brain Cancer Therapeutic Candidate
Funding & Breakthroughs, Highlights, News, Press releasesSpain & India, working in the clinical development for a novel therapy against pediatric brain tumors
HighlightsGate2Brain part of the CDTI’s NEOTEC program
Highlights, NewsGate2Brain receives €2,5M funding from EIC to develop its technology
Highlights, Press releasesThree University of Barcelona spin-offs receive funding from Women TechEU
Highlights, NewsBStartup of Banco de Sabadell invests in Gate2Brain biotech
Funding & Breakthroughs, Highlights, Press releasesThe Mind the Gap program of Botín Foundation invests 1.5 million euros in three new biotech startups
Highlights, Media & Press, Press releasesNews & Media
EIC and J&J Healthcare Investor Day
NewsBioPharma Formulation & Delivery Nexus Conference
EventsGate2brain or the innovative solution for pediatric brain tumors
Interviews, Media & Press, NewsBIO-EUROPE STOCKHOLM
Events, Funding & BreakthroughsGate2Brain 4-Year Journey
NewsGate2Brain is attending BioJapan 2024
EventsJump4Women – Trip to Boston
NewsGate2Brain is Virtually Partnering at RESIBOSTON!
Events, Funding & BreakthroughsGate2Brain’s Summer Retreat 2024
EventsBack to Work with Peptides
Events, NewsFernando Albericio – Meet the Advisory Board
Advisory Board, G2B family, NewsBreaking Barriers in Science: The Journey of Meritxell Teixidó and Gate2Brain
Interviews, Media & Press, NewsGate2Brain and Intact Barrier Brain Tumors: A Ray of Hope in the Fight against DIPG
Media & Press, NewsAlejandro Sosnik – Meet the Team
NewsMeritxell Teixidó, Entrepreneurial Advisory Board member of The Peptide Drug Hunting Consortium
News